BBT Capital Management’s Boston Scientific BSX Stock Holding History

BBT Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-65,000	Closed	-$1.07M	–	109
2015 Q3	$1.07M	Sell	65,000 -35,000	-35%	-$598K	0.1%	113
2015 Q2	$1.77M	Buy	+100,000	New	+$1.79M	0.16%	104
2014 Q2	–	Sell	-500,000	Closed	-$6.76M	–	222
2014 Q1	$6.76M	Buy	+500,000	New	+$6.56M	0.31%	81

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

BBT Capital Management's BSX Position: Q2 2019 in Review

BBT Capital Management sold out of Boston Scientific (BSX) in Q2 2019, closing a stake of 7,644 shares — an estimated $293K sold.

BBT Capital Management first reported a position in BSX in Q1 2019 and held it in 1 quarter. The position peaked at $293K in Q1 2019. 757 funds tracked by Wall St. Rank hold BSX as of Q2 2019.

BBT Capital Management reported no remaining Boston Scientific position as of Q2 2019 after selling out during the quarter.
BBT Capital Management sold 7,644 Boston Scientific shares in Q2 2019, an estimated $293K.
BBT Capital Management first reported a position in Boston Scientific in Q1 2019 and held it in 1 quarter.
BBT Capital Management's Boston Scientific position peaked at $293K in Q1 2019.
757 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2019.

Based on BBT Capital Management's 13F filing for Q2 2019, filed 9 Aug 2019.